Psoriasis and comorbid diseases: Implications for management
As summarized in the first article in this continuing medical education series, the currently available epidemiologic data suggest that psoriasis may be a risk factor for cardiometabolic disease. Emerging data also suggest associations between psoriasis and other comorbidities beyond psoriatic arthr...
Gespeichert in:
| Veröffentlicht in: | Journal of the American Academy of Dermatology 2017-03, Vol.76 (3), p.393 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 3 |
| container_start_page | 393 |
| container_title | Journal of the American Academy of Dermatology |
| container_volume | 76 |
| creator | Takeshita, Junko Grewal, Sungat Langan, Sinéad M Mehta, Nehal N Ogdie, Alexis Van Voorhees, Abby S Gelfand, Joel M |
| description | As summarized in the first article in this continuing medical education series, the currently available epidemiologic data suggest that psoriasis may be a risk factor for cardiometabolic disease. Emerging data also suggest associations between psoriasis and other comorbidities beyond psoriatic arthritis, including chronic kidney disease, inflammatory bowel disease, hepatic disease, certain malignancies, infections, and mood disorders. Recognizing the comorbid disease burden of psoriasis is essential for ensuring comprehensive care of patients with psoriasis. The clinical implications of the comorbid diseases that are associated with psoriasis and recommendations for clinical management are reviewed in this article. |
| doi_str_mv | 10.1016/j.jaad.2016.07.065 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1869967981</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1869967981</sourcerecordid><originalsourceid>FETCH-LOGICAL-p211t-883fa2c0d13c5d05e5c796d81113642340b7dda50cf21b3f7beb965bbb778f5e3</originalsourceid><addsrcrecordid>eNpNj8tKxDAYRoMozjj6Ai6kSzet-ZPmJm5k8DIwoAtdl9wqKU1Tm87Ct58BR3D1ncXhwIfQNeAKMPC7ruq0dhU5cIVFhTk7QUvASpRcSHH6jxfoIucOY6xqKs7RgkgCRHC8RA_vOU1B55ALPbjCppgmE1zhQvY6-3xfbOLYB6vnkIZctGkqoh70l49-mC_RWav77K-Ou0Kfz08f69dy-_ayWT9uy5EAzKWUtNXEYgfUMoeZZ1Yo7iQAUF4TWmMjnNMM25aAoa0w3ijOjDFCyJZ5ukK3v91xSt87n-cmhmx93-vBp11uQHKluFASDurNUd2Z6F0zTiHq6af5e0z3VhZY-w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1869967981</pqid></control><display><type>article</type><title>Psoriasis and comorbid diseases: Implications for management</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Takeshita, Junko ; Grewal, Sungat ; Langan, Sinéad M ; Mehta, Nehal N ; Ogdie, Alexis ; Van Voorhees, Abby S ; Gelfand, Joel M</creator><creatorcontrib>Takeshita, Junko ; Grewal, Sungat ; Langan, Sinéad M ; Mehta, Nehal N ; Ogdie, Alexis ; Van Voorhees, Abby S ; Gelfand, Joel M</creatorcontrib><description>As summarized in the first article in this continuing medical education series, the currently available epidemiologic data suggest that psoriasis may be a risk factor for cardiometabolic disease. Emerging data also suggest associations between psoriasis and other comorbidities beyond psoriatic arthritis, including chronic kidney disease, inflammatory bowel disease, hepatic disease, certain malignancies, infections, and mood disorders. Recognizing the comorbid disease burden of psoriasis is essential for ensuring comprehensive care of patients with psoriasis. The clinical implications of the comorbid diseases that are associated with psoriasis and recommendations for clinical management are reviewed in this article.</description><identifier>ISSN: 1097-6787</identifier><identifier>EISSN: 1097-6787</identifier><identifier>DOI: 10.1016/j.jaad.2016.07.065</identifier><identifier>PMID: 28212760</identifier><language>eng</language><publisher>United States</publisher><subject>Cardiovascular Diseases - epidemiology ; Cardiovascular Diseases - prevention & control ; Comorbidity ; Contraindications ; Diabetes Mellitus - diagnosis ; Diabetes Mellitus - epidemiology ; Dyslipidemias - epidemiology ; Humans ; Immunosuppressive Agents - therapeutic use ; Infections - diagnosis ; Infections - epidemiology ; Inflammatory Bowel Diseases - drug therapy ; Inflammatory Bowel Diseases - epidemiology ; Liver Diseases - epidemiology ; Mood Disorders - diagnosis ; Mood Disorders - epidemiology ; Obesity - epidemiology ; Obesity - therapy ; Psoriasis - drug therapy ; Psoriasis - epidemiology ; Psoriasis - therapy ; Renal Insufficiency, Chronic - epidemiology ; Risk Factors ; Skin Neoplasms - chemically induced ; Skin Neoplasms - diagnosis ; Skin Neoplasms - epidemiology ; Tumor Necrosis Factor-alpha - antagonists & inhibitors</subject><ispartof>Journal of the American Academy of Dermatology, 2017-03, Vol.76 (3), p.393</ispartof><rights>Copyright © 2016 American Academy of Dermatology, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28212760$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Takeshita, Junko</creatorcontrib><creatorcontrib>Grewal, Sungat</creatorcontrib><creatorcontrib>Langan, Sinéad M</creatorcontrib><creatorcontrib>Mehta, Nehal N</creatorcontrib><creatorcontrib>Ogdie, Alexis</creatorcontrib><creatorcontrib>Van Voorhees, Abby S</creatorcontrib><creatorcontrib>Gelfand, Joel M</creatorcontrib><title>Psoriasis and comorbid diseases: Implications for management</title><title>Journal of the American Academy of Dermatology</title><addtitle>J Am Acad Dermatol</addtitle><description>As summarized in the first article in this continuing medical education series, the currently available epidemiologic data suggest that psoriasis may be a risk factor for cardiometabolic disease. Emerging data also suggest associations between psoriasis and other comorbidities beyond psoriatic arthritis, including chronic kidney disease, inflammatory bowel disease, hepatic disease, certain malignancies, infections, and mood disorders. Recognizing the comorbid disease burden of psoriasis is essential for ensuring comprehensive care of patients with psoriasis. The clinical implications of the comorbid diseases that are associated with psoriasis and recommendations for clinical management are reviewed in this article.</description><subject>Cardiovascular Diseases - epidemiology</subject><subject>Cardiovascular Diseases - prevention & control</subject><subject>Comorbidity</subject><subject>Contraindications</subject><subject>Diabetes Mellitus - diagnosis</subject><subject>Diabetes Mellitus - epidemiology</subject><subject>Dyslipidemias - epidemiology</subject><subject>Humans</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Infections - diagnosis</subject><subject>Infections - epidemiology</subject><subject>Inflammatory Bowel Diseases - drug therapy</subject><subject>Inflammatory Bowel Diseases - epidemiology</subject><subject>Liver Diseases - epidemiology</subject><subject>Mood Disorders - diagnosis</subject><subject>Mood Disorders - epidemiology</subject><subject>Obesity - epidemiology</subject><subject>Obesity - therapy</subject><subject>Psoriasis - drug therapy</subject><subject>Psoriasis - epidemiology</subject><subject>Psoriasis - therapy</subject><subject>Renal Insufficiency, Chronic - epidemiology</subject><subject>Risk Factors</subject><subject>Skin Neoplasms - chemically induced</subject><subject>Skin Neoplasms - diagnosis</subject><subject>Skin Neoplasms - epidemiology</subject><subject>Tumor Necrosis Factor-alpha - antagonists & inhibitors</subject><issn>1097-6787</issn><issn>1097-6787</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNj8tKxDAYRoMozjj6Ai6kSzet-ZPmJm5k8DIwoAtdl9wqKU1Tm87Ct58BR3D1ncXhwIfQNeAKMPC7ruq0dhU5cIVFhTk7QUvASpRcSHH6jxfoIucOY6xqKs7RgkgCRHC8RA_vOU1B55ALPbjCppgmE1zhQvY6-3xfbOLYB6vnkIZctGkqoh70l49-mC_RWav77K-Ou0Kfz08f69dy-_ayWT9uy5EAzKWUtNXEYgfUMoeZZ1Yo7iQAUF4TWmMjnNMM25aAoa0w3ijOjDFCyJZ5ukK3v91xSt87n-cmhmx93-vBp11uQHKluFASDurNUd2Z6F0zTiHq6af5e0z3VhZY-w</recordid><startdate>201703</startdate><enddate>201703</enddate><creator>Takeshita, Junko</creator><creator>Grewal, Sungat</creator><creator>Langan, Sinéad M</creator><creator>Mehta, Nehal N</creator><creator>Ogdie, Alexis</creator><creator>Van Voorhees, Abby S</creator><creator>Gelfand, Joel M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201703</creationdate><title>Psoriasis and comorbid diseases: Implications for management</title><author>Takeshita, Junko ; Grewal, Sungat ; Langan, Sinéad M ; Mehta, Nehal N ; Ogdie, Alexis ; Van Voorhees, Abby S ; Gelfand, Joel M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p211t-883fa2c0d13c5d05e5c796d81113642340b7dda50cf21b3f7beb965bbb778f5e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Cardiovascular Diseases - epidemiology</topic><topic>Cardiovascular Diseases - prevention & control</topic><topic>Comorbidity</topic><topic>Contraindications</topic><topic>Diabetes Mellitus - diagnosis</topic><topic>Diabetes Mellitus - epidemiology</topic><topic>Dyslipidemias - epidemiology</topic><topic>Humans</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Infections - diagnosis</topic><topic>Infections - epidemiology</topic><topic>Inflammatory Bowel Diseases - drug therapy</topic><topic>Inflammatory Bowel Diseases - epidemiology</topic><topic>Liver Diseases - epidemiology</topic><topic>Mood Disorders - diagnosis</topic><topic>Mood Disorders - epidemiology</topic><topic>Obesity - epidemiology</topic><topic>Obesity - therapy</topic><topic>Psoriasis - drug therapy</topic><topic>Psoriasis - epidemiology</topic><topic>Psoriasis - therapy</topic><topic>Renal Insufficiency, Chronic - epidemiology</topic><topic>Risk Factors</topic><topic>Skin Neoplasms - chemically induced</topic><topic>Skin Neoplasms - diagnosis</topic><topic>Skin Neoplasms - epidemiology</topic><topic>Tumor Necrosis Factor-alpha - antagonists & inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Takeshita, Junko</creatorcontrib><creatorcontrib>Grewal, Sungat</creatorcontrib><creatorcontrib>Langan, Sinéad M</creatorcontrib><creatorcontrib>Mehta, Nehal N</creatorcontrib><creatorcontrib>Ogdie, Alexis</creatorcontrib><creatorcontrib>Van Voorhees, Abby S</creatorcontrib><creatorcontrib>Gelfand, Joel M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Academy of Dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Takeshita, Junko</au><au>Grewal, Sungat</au><au>Langan, Sinéad M</au><au>Mehta, Nehal N</au><au>Ogdie, Alexis</au><au>Van Voorhees, Abby S</au><au>Gelfand, Joel M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Psoriasis and comorbid diseases: Implications for management</atitle><jtitle>Journal of the American Academy of Dermatology</jtitle><addtitle>J Am Acad Dermatol</addtitle><date>2017-03</date><risdate>2017</risdate><volume>76</volume><issue>3</issue><spage>393</spage><pages>393-</pages><issn>1097-6787</issn><eissn>1097-6787</eissn><abstract>As summarized in the first article in this continuing medical education series, the currently available epidemiologic data suggest that psoriasis may be a risk factor for cardiometabolic disease. Emerging data also suggest associations between psoriasis and other comorbidities beyond psoriatic arthritis, including chronic kidney disease, inflammatory bowel disease, hepatic disease, certain malignancies, infections, and mood disorders. Recognizing the comorbid disease burden of psoriasis is essential for ensuring comprehensive care of patients with psoriasis. The clinical implications of the comorbid diseases that are associated with psoriasis and recommendations for clinical management are reviewed in this article.</abstract><cop>United States</cop><pmid>28212760</pmid><doi>10.1016/j.jaad.2016.07.065</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1097-6787 |
| ispartof | Journal of the American Academy of Dermatology, 2017-03, Vol.76 (3), p.393 |
| issn | 1097-6787 1097-6787 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1869967981 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
| subjects | Cardiovascular Diseases - epidemiology Cardiovascular Diseases - prevention & control Comorbidity Contraindications Diabetes Mellitus - diagnosis Diabetes Mellitus - epidemiology Dyslipidemias - epidemiology Humans Immunosuppressive Agents - therapeutic use Infections - diagnosis Infections - epidemiology Inflammatory Bowel Diseases - drug therapy Inflammatory Bowel Diseases - epidemiology Liver Diseases - epidemiology Mood Disorders - diagnosis Mood Disorders - epidemiology Obesity - epidemiology Obesity - therapy Psoriasis - drug therapy Psoriasis - epidemiology Psoriasis - therapy Renal Insufficiency, Chronic - epidemiology Risk Factors Skin Neoplasms - chemically induced Skin Neoplasms - diagnosis Skin Neoplasms - epidemiology Tumor Necrosis Factor-alpha - antagonists & inhibitors |
| title | Psoriasis and comorbid diseases: Implications for management |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T20%3A48%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Psoriasis%20and%20comorbid%20diseases:%20Implications%20for%20management&rft.jtitle=Journal%20of%20the%20American%20Academy%20of%20Dermatology&rft.au=Takeshita,%20Junko&rft.date=2017-03&rft.volume=76&rft.issue=3&rft.spage=393&rft.pages=393-&rft.issn=1097-6787&rft.eissn=1097-6787&rft_id=info:doi/10.1016/j.jaad.2016.07.065&rft_dat=%3Cproquest_pubme%3E1869967981%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1869967981&rft_id=info:pmid/28212760&rfr_iscdi=true |